1. Home
  2. OPENW vs VRXAW Comparison

OPENW vs VRXAW Comparison

Compare OPENW & VRXAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies

OPENW

Opendoor Technologies

N/A

Current Price

$0.20

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Veraxa Biotech AG Warrants

VRXAW

Veraxa Biotech AG Warrants

N/A

Current Price

$0.09

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPENW
VRXAW
Founded
N/A
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
OPENW
VRXAW
Price
$0.20
$0.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
292.2K
49.5K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,371,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.08
52 Week High
$1.95
$0.23

Technical Indicators

Market Signals
Indicator
OPENW
VRXAW
Relative Strength Index (RSI) 32.93 40.26
Support Level $0.20 N/A
Resistance Level $0.85 $0.17
Average True Range (ATR) 0.05 0.01
MACD -0.01 -0.00
Stochastic Oscillator 2.66 8.02

Price Performance

Historical Comparison
OPENW
VRXAW

About OPENW Opendoor Technologies

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About VRXAW Veraxa Biotech AG Warrants

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: